Understanding Challenges, Behavioral Patterns, And Preferences Toward Participation In Clinical Trials In Minority Patient Populations: Development Of A Personalized Clinical Trial Educational Platform To Increase Participation In Clinical Trials Among Underserved Cancer Patients

Overview

About this study

This clinical trial investigates the challenges, behavioral patterns, and preferences towards participation in clinical trials in minority patient populations in order to develop a personalized clinical trial educational platform to increase participation in clinical trials among underserved cancer patients. Learning more about patients' understanding of clinical trials may help identify barriers that limit patient's participation. Information gathered from this trial will be used to develop educational materials that may aid minority patients in overcoming barriers to participating in clinical trials. A personalized clinical trial educational platform may help increase participation in clinical trials among minority populations.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

* PART I: Subjects must be adults with age \>= 18 years at the time of study entry
* PART I: Subjects with any cancer diagnosis may be included
* PART I: Subjects must be identified as new patients to hematology oncology at the treating site
* PART I: Subjects must be willing to provide informed consent for the study
* PART II: Subjects must be adults with age \>= 18 years at the time of study entry
* PART II: Subjects with any cancer diagnosis may be included
* PART II: Subjects must be identified as new patients to hematology oncology at the treating site
* PART II: Subjects must be willing to provide informed consent for the study

Exclusion Criteria:

* PART I: Patients reported to have an estimated life-expectancy of \< 6 months, as assessed by their clinician
* PART I: Patients not willing to complete the Clinical Trials Study survey
* PART II: Patients reported to have an estimated life-expectancy of \< 6 months, as assessed by their clinician
* PART II: Patients not willing to complete the education intervention or continued follow up for at least 2 years

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Cassandra Moore, M.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

Jacksonville, Fla.

Mayo Clinic principal investigator

Sikander Ailawadhi, M.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

Rochester, Minn.

Mayo Clinic principal investigator

Rahma Warsame, M.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available